The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2024 | Fraser Craig | President and CEO, Director | Buy(P) | 5K | $0.91 | $5K |
| Jul 22, 2024 | Fraser Craig | President and CEO, Director | Grant(A) | 19 | — | — |
| Jul 22, 2024 | Fraser Craig | President and CEO, Director | Grant(A) | 4K | — | — |
| Jul 22, 2024 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 3K | — | — |
| Jul 22, 2024 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 13 | — | — |
| Sep 27, 2023 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $1.02 | $3K |
| Sep 26, 2023 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $0.90 | $2K |
| Aug 23, 2023 | Fraser Craig | President and CEO, Director | Grant(A) | 46K | — | $0 |
| Aug 23, 2023 | Fraser Craig | President and CEO, Director | Grant(A) | 69K | — | $0 |
| Aug 23, 2023 | Curtis Eric | SVP & COO | Grant(A) | 15K | — | $0 |
| Aug 23, 2023 | Curtis Eric | SVP & COO | Grant(A) | 22K | — | $0 |
| Aug 23, 2023 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 16K | — | $0 |
| Aug 23, 2023 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Aug 23, 2023 | Scott Robert A | Director | Grant(A) | 2K | — | $0 |
| Aug 23, 2023 | Scott Robert A | Director | Grant(A) | 3K | — | $0 |
| Aug 23, 2023 | Strobeck Mark | Director | Grant(A) | 2K | — | $0 |
| Aug 23, 2023 | Strobeck Mark | Director | Grant(A) | 3K | — | $0 |
| Aug 23, 2023 | Williams Leslie J. | Director | Grant(A) | 2K | — | $0 |
| Aug 23, 2023 | Williams Leslie J. | Director | Grant(A) | 3K | — | $0 |
| Aug 23, 2023 | Geffken Daniel E. | Director | Grant(A) | 2K | — | $0 |
| Aug 23, 2023 | Geffken Daniel E. | Director | Grant(A) | 3K | — | $0 |
| Apr 26, 2023 | Fraser Craig | President and CEO, Director | Buy(P) | 1K | $1.77 | $3K |
| Apr 25, 2023 | Fraser Craig | President and CEO, Director | Buy(P) | 1K | $1.89 | $2K |
| Feb 28, 2023 | Carman Diane | SVP & General Counsel | Tax withholding(F) | 99 | — | $0 |
| Feb 28, 2023 | Curtis Eric | SVP & COO | Tax withholding(F) | 99 | — | $0 |
| Feb 28, 2023 | Fraser Craig | President and CEO, Director | Tax withholding(F) | 334 | — | $0 |
| Feb 28, 2023 | Simonson Steven | SVP, Chief Medical Officer | Tax withholding(F) | 100 | — | $0 |
| Feb 22, 2023 | Huang James | Director | Option exercise(X) | 1.1M | $0.14 | $156K |
| Feb 22, 2023 | Huang James | Director | Disposed to issuer(D) | 276K | — | $0 |
| Feb 22, 2023 | Huang James | Director | Disposed to issuer(D) | 276K | — | $0 |
| Feb 22, 2023 | Huang James | Director | Disposed to issuer(D) | 498K | — | $0 |
| Feb 22, 2023 | Huang James | Director | Grant(A) | 2.2M | — | $0 |
| Feb 22, 2023 | Huang James | Director | Disposed to issuer(D) | 63K | — | $0 |
| Feb 22, 2023 | Huang James | Director | Grant(A) | 1.1M | — | $0 |
| Feb 22, 2023 | Huang James | Director | Option exercise(X) | 1.1M | — | $0 |
| Jul 27, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $0.38 | $950 |
| Jul 26, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $0.37 | $925 |
| Jul 26, 2022 | Hamill John P. | SVP & CFO | Buy(P) | 3K | $0.37 | $1K |
| Jun 30, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 5K | $0.43 | $2K |
| Jun 29, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 7K | $0.42 | $3K |
| Jun 7, 2022 | Geffken Daniel E. | Director | Grant(A) | 5K | — | $0 |
| Jun 7, 2022 | Geffken Daniel E. | Director | Grant(A) | 8K | — | $0 |
| Jun 7, 2022 | Huang James | Director | Grant(A) | 5K | — | $0 |
| Jun 7, 2022 | Huang James | Director | Grant(A) | 8K | — | $0 |
| Jun 7, 2022 | Scott Robert A | Director | Grant(A) | 5K | — | $0 |
| Jun 7, 2022 | Scott Robert A | Director | Grant(A) | 8K | — | $0 |
| Jun 7, 2022 | Williams Leslie J. | Director | Grant(A) | 5K | — | $0 |
| Jun 7, 2022 | Williams Leslie J. | Director | Grant(A) | 8K | — | $0 |
| Mar 16, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 2K | $0.98 | $2K |
| Mar 15, 2022 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $0.98 | $3K |
| Mar 15, 2022 | Simonson Steven | SVP, Chief Medical Officer | Buy(P) | 5K | $1.00 | $5K |
| Mar 4, 2022 | Carman Diane | SVP & General Counsel | Grant(A) | 66K | — | $0 |
| Mar 4, 2022 | Carman Diane | SVP & General Counsel | Grant(A) | 100K | — | $0 |
| Mar 4, 2022 | Curtis Eric | SVP & COO | Grant(A) | 66K | — | $0 |
| Mar 4, 2022 | Curtis Eric | SVP & COO | Grant(A) | 100K | — | $0 |
| Mar 4, 2022 | Fraser Craig | President and CEO, Director | Grant(A) | 167K | — | $0 |
| Mar 4, 2022 | Fraser Craig | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Mar 4, 2022 | Hamill John P. | SVP & CFO | Grant(A) | 66K | — | $0 |
| Mar 4, 2022 | Hamill John P. | SVP & CFO | Grant(A) | 100K | — | $0 |
| Mar 4, 2022 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Mar 4, 2022 | Simonson Steven | SVP, Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Dec 30, 2021 | Bioengine Capital Inc. | 10% Owner | Sell(S) | 1.2M | $1.60 | $2.0M |
| Dec 30, 2021 | Center Laboratories, Inc. | 10% Owner | Buy(P) | 1.2M | $1.60 | $2.0M |
| Nov 19, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 930 | $1.60 | $1K |
| Nov 18, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 930 | $1.61 | $1K |
| Oct 22, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $1.90 | $6K |
| Oct 19, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 3K | $1.91 | $6K |
| Oct 19, 2021 | Huang James | Director | Buy(P) | 50K | $1.90 | $95K |
| Jul 1, 2021 | Carman Diane | SVP & General Counsel | Grant(A) | 150K | — | $0 |
| Jun 15, 2021 | Huang James | Director | Grant(A) | 15K | — | $0 |
| Jun 15, 2021 | Geffken Daniel E. | Director | Grant(A) | 15K | — | $0 |
| Apr 16, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 1K | $2.09 | $2K |
| Apr 16, 2021 | Hamill John P. | SVP & CFO | Buy(P) | 1K | $2.07 | $2K |
| Apr 15, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 1K | $2.24 | $2K |
| Apr 7, 2021 | Curtis Eric | SVP & COO | Buy(P) | 791 | $2.52 | $2K |
| Apr 6, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 500 | $2.57 | $1K |
| Apr 5, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 1K | $2.58 | $3K |
| Apr 1, 2021 | Fraser Craig | President and CEO, Director | Buy(P) | 500 | $2.46 | $1K |
| Mar 31, 2021 | Huang James | Director, 10% Owner | Buy(P) | 150K | $2.36 | $354K |
| Jun 24, 2020 | Bioengine Capital Inc. | 10% Owner | Other(J) | 0 | — | $0 |
| Jun 24, 2020 | Center Laboratories, Inc. | 10% Owner | Other(J) | 0 | — | $0 |
| May 20, 2020 | Bioengine Capital Inc. | 10% Owner | Other(J) | 3.6M | — | $0 |
| May 20, 2020 | Bioengine Capital Inc. | 10% Owner | Buy(P) | 55K | $7.25 | $400K |
| May 20, 2020 | Bioengine Capital Inc. | 10% Owner | Buy(P) | 55K | — | $0 |
| May 20, 2020 | Bioengine Capital Inc. | 10% Owner | Other(J) | 249K | — | $0 |
| May 20, 2020 | Center Laboratories, Inc. | 10% Owner | Buy(P) | 55K | $7.25 | $400K |
| May 20, 2020 | Center Laboratories, Inc. | 10% Owner | Other(J) | 3.6M | — | $0 |
| May 20, 2020 | Center Laboratories, Inc. | 10% Owner | Other(J) | 249K | — | $0 |
| May 20, 2020 | Center Laboratories, Inc. | 10% Owner | Buy(P) | 55K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).